First Time Loading...
P

Purple Biotech Ltd
TASE:PPBT

Watchlist Manager
Purple Biotech Ltd
TASE:PPBT
Watchlist
Price: 20 ILS -10.31% Market Closed
Updated: May 5, 2024

Purple Biotech Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Purple Biotech Ltd
Operating Income Peer Comparison

Comparables:
T
TEVA
TARO
I
INCR
MDWD
R
REKA

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
P
Purple Biotech Ltd
TASE:PPBT
Operating Income
-$22.6m
CAGR 3-Years
-48%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
T
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Operating Income
$3.5B
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
-1%
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Operating Income
$22m
CAGR 3-Years
-49%
CAGR 5-Years
-40%
CAGR 10-Years
-25%
I
InterCure Ltd
TASE:INCR
Operating Income
₪40m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Operating Income
-$15.5m
CAGR 3-Years
-21%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Operating Income
₪5.6m
CAGR 3-Years
-31%
CAGR 5-Years
-16%
CAGR 10-Years
-10%

See Also

What is Purple Biotech Ltd's Operating Income?
Operating Income
-22.6m USD

Based on the financial report for Dec 31, 2022, Purple Biotech Ltd's Operating Income amounts to -22.6m USD.

What is Purple Biotech Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-15%

Over the last year, the Operating Income growth was -26%. The average annual Operating Income growth rates for Purple Biotech Ltd have been -48% over the past three years , -15% over the past five years .